Workflow
NUTX DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Nutex Health Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on October 21, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Nutex securities between August 8, 2024, and August 14, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must act by the lead plaintiff deadline to represent other class members [2][6]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. Group 3: Case Allegations - The lawsuit alleges that Nutex made false and misleading statements regarding its financial practices, including the engagement with HaloMD, which allegedly defrauded insurance companies [4]. - It is claimed that Nutex overstated its financial health and internal controls, leading to improper accounting of stock-based compensation obligations [4]. - The lawsuit asserts that these misrepresentations resulted in damages to investors when the true details became public [4].